With approval for new drug, Alexion aims to switch patients from Soliris

With approval for new drug, Alexion aims to switch patients from Soliris

Alexion wins approval for rare disease drug, aims to switch patients from blockbuster Soliris

By ADAM FEUERSTEIN

KRISTOFFER TRIPPLAAR/SIPA/AP

A new drug called Ultomiris that will be used to treat an ultra-rare blood disease and ultimately replace the current blockbuster product, Soliris.

READ MORE